AVESTHAGEN LIMITED Patent applications |
Patent application number | Title | Published |
20120022017 | COMPOSITION AND A METHOD THEREOF - The present invention describes a palatable and orally administrable form of composition comprising proteins, galactomannans and base matrix optionally along with acceptable additives. | 01-26-2012 |
20120017334 | Nitrogen Use Efficient Transgenic Plants - The present invention relates to glutamate decarboxylase (GAD) gene sequence isolated from | 01-19-2012 |
20110231956 | Environmentally Adjusted Transgenic Plants - The present invention relates to a novel transgenic plant having tolerance to salt stress. The plant is transformed with a recombinant nucleic acid encoding glutamic acid decarboxylase isolated from | 09-22-2011 |
20110204222 | METHOD OF CHARACTERIZING PHYTOCHEMICALS FROM TRIGONELLA FOENUM GRACEUM - The present invention relates to identification and characterization of Phytochemicals and metabolites from | 08-25-2011 |
20110190482 | POLYMER ENCAPSULATED ALUMINUM PARTICULATES - The present invention relates to use of novel bioinformatics approach for predicting and identifying Scaffold/Matrix attachment regions (S/MARs) from different genomic database. | 08-04-2011 |
20100247638 | ORGANOLEPTICALLY IMPROVED DIETARY FIBER COMPOSITION AND A PROCESS THEREOF (TEESTAR) - The present invention is in relation to an organoleptically improved dietary fiber composition from | 09-30-2010 |
20100120103 | Recombinant Production Docosahexaenoic Acid (DHA) in Yeast - The present invention relates to a specifically novel recombinant method of production of the omega-3 fatty acid, Docosahexaenoic acid by a potentially safe recombinant organism | 05-13-2010 |
20090068721 | Process for the Production of Recombinant Activated Human Protein C for the Treatment of Sepsis - The present invention relates to a recombinant method of production of activated Protein C. The invention relates to a method of construction, transformation, expression, purification and production of recombinant activated human protein C. DNA constructs comprising the control elements associated with the gene of interest has been disclosed. The nucleic acid sequence of interest has been codon optimized to permit expression in the suitable mammalian host cells. | 03-12-2009 |
20090029907 | Recombinant Method for Production of an Erythropoiesis Stimulating Protein - The present invention relates to the recombinant method used for the production of a highly glycosylated form (in total five N linked glycosylations as opposed to three N linked glyosylations in the natural EPO) of erythropoietin. The added sites for glycosylation will result in greater number of carbohydrate chains, and higher sialic acid content than human EPO, which in turn would impart to the recombinant molecule a longer half-life. The invention further relates to the construction of expression cassettes comprising nucleic acid sequences encoding for the highly glycosylated form of Erythropoietin and stable expression in the host cells. The invention further relates to the optimized method for purification of the erythropoiesis stimulating protein. The recombinant EPO according to the invention, and the salts and functional derivatives thereof, may comprise the active ingredient of pharmaceutical compositions for an increase in the hematocrit for treatment of anemia and for restoration of patient well being and quality of life. | 01-29-2009 |